Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lymphoma, Non-Hodgkin | 27 | 2024 | 1372 | 4.520 |
Why?
|
Multiple Myeloma | 28 | 2024 | 5146 | 2.110 |
Why?
|
Trans Fatty Acids | 2 | 2020 | 155 | 1.190 |
Why?
|
HTLV-I Infections | 3 | 2009 | 103 | 0.800 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 6 | 2022 | 1405 | 0.750 |
Why?
|
Hodgkin Disease | 6 | 2024 | 1378 | 0.730 |
Why?
|
Erythrocyte Membrane | 1 | 2020 | 439 | 0.650 |
Why?
|
Body Mass Index | 13 | 2024 | 12943 | 0.630 |
Why?
|
Anthropometry | 4 | 2024 | 1338 | 0.610 |
Why?
|
Body Size | 3 | 2022 | 463 | 0.610 |
Why?
|
Fatty Acids, Monounsaturated | 1 | 2018 | 190 | 0.580 |
Why?
|
Lymphoma, Follicular | 5 | 2022 | 457 | 0.550 |
Why?
|
Case-Control Studies | 37 | 2024 | 22148 | 0.540 |
Why?
|
Aspirin | 2 | 2021 | 3127 | 0.540 |
Why?
|
Fatty Acids, Omega-3 | 2 | 2023 | 1390 | 0.530 |
Why?
|
Diet | 5 | 2021 | 8048 | 0.520 |
Why?
|
Prospective Studies | 33 | 2024 | 54360 | 0.500 |
Why?
|
Risk Factors | 48 | 2024 | 74115 | 0.500 |
Why?
|
Herpesvirus 4, Human | 6 | 2017 | 1077 | 0.480 |
Why?
|
Nurses | 4 | 2021 | 2477 | 0.470 |
Why?
|
Fatty Acids | 3 | 2023 | 1808 | 0.470 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2021 | 2270 | 0.460 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 7 | 2022 | 1639 | 0.440 |
Why?
|
Interleukin-6 | 3 | 2017 | 3206 | 0.430 |
Why?
|
Epstein-Barr Virus Infections | 4 | 2017 | 612 | 0.430 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2012 | 1932 | 0.420 |
Why?
|
Obesity | 9 | 2024 | 12933 | 0.420 |
Why?
|
Dietary Fats | 2 | 2018 | 1995 | 0.410 |
Why?
|
HIV Seronegativity | 1 | 2013 | 211 | 0.410 |
Why?
|
Genetic Predisposition to Disease | 17 | 2023 | 17878 | 0.400 |
Why?
|
Epstein-Barr Virus Nuclear Antigens | 2 | 2011 | 157 | 0.380 |
Why?
|
Endometrial Neoplasms | 2 | 2022 | 1365 | 0.380 |
Why?
|
Follow-Up Studies | 20 | 2024 | 39063 | 0.370 |
Why?
|
Hematologic Neoplasms | 3 | 2024 | 1896 | 0.350 |
Why?
|
Middle Aged | 65 | 2024 | 220584 | 0.350 |
Why?
|
Genome-Wide Association Study | 16 | 2023 | 12661 | 0.340 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 2 | 2022 | 179 | 0.320 |
Why?
|
Proportional Hazards Models | 10 | 2023 | 12447 | 0.320 |
Why?
|
Adult | 60 | 2024 | 220969 | 0.310 |
Why?
|
Feeding Behavior | 2 | 2017 | 3182 | 0.300 |
Why?
|
Polymorphism, Single Nucleotide | 20 | 2023 | 15908 | 0.280 |
Why?
|
Aged | 45 | 2024 | 169042 | 0.280 |
Why?
|
Humans | 104 | 2024 | 760617 | 0.280 |
Why?
|
Antibodies, Viral | 4 | 2011 | 3150 | 0.280 |
Why?
|
Lymphoma, B-Cell | 3 | 2020 | 938 | 0.280 |
Why?
|
Female | 72 | 2024 | 392148 | 0.270 |
Why?
|
Clone Cells | 3 | 2019 | 1657 | 0.270 |
Why?
|
Male | 66 | 2024 | 360358 | 0.270 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 2 | 2020 | 178 | 0.260 |
Why?
|
Neoplasm Proteins | 1 | 2018 | 3607 | 0.260 |
Why?
|
Body Height | 3 | 2023 | 1565 | 0.250 |
Why?
|
Young Adult | 24 | 2024 | 59179 | 0.240 |
Why?
|
HTLV-I Antibodies | 1 | 2004 | 35 | 0.240 |
Why?
|
Odds Ratio | 10 | 2020 | 9643 | 0.240 |
Why?
|
Autoimmune Diseases | 4 | 2022 | 2238 | 0.240 |
Why?
|
Neoplasms | 7 | 2024 | 22131 | 0.240 |
Why?
|
Ovarian Neoplasms | 3 | 2021 | 4849 | 0.240 |
Why?
|
Hematopoiesis | 3 | 2019 | 2049 | 0.230 |
Why?
|
Tattooing | 1 | 2024 | 57 | 0.230 |
Why?
|
Hepatitis C Antibodies | 1 | 2004 | 146 | 0.230 |
Why?
|
Viral Proteins | 1 | 2011 | 1799 | 0.230 |
Why?
|
Burkitt Lymphoma | 2 | 2018 | 335 | 0.230 |
Why?
|
Chromosomes, Human | 2 | 2017 | 441 | 0.220 |
Why?
|
Carrier State | 1 | 2006 | 522 | 0.200 |
Why?
|
Life Style | 5 | 2016 | 3904 | 0.190 |
Why?
|
Trust | 2 | 2023 | 528 | 0.190 |
Why?
|
Risk | 8 | 2017 | 9604 | 0.190 |
Why?
|
Chemokine CXCL13 | 1 | 2021 | 59 | 0.180 |
Why?
|
Hair Dyes | 1 | 2020 | 30 | 0.180 |
Why?
|
Pesticide Residues | 1 | 2021 | 95 | 0.180 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2022 | 237 | 0.170 |
Why?
|
Cytokines | 2 | 2021 | 7373 | 0.170 |
Why?
|
Exercise | 3 | 2018 | 5886 | 0.170 |
Why?
|
Osteosarcoma | 2 | 2023 | 896 | 0.170 |
Why?
|
Connecticut | 3 | 2015 | 364 | 0.160 |
Why?
|
Hydrocarbons, Aromatic | 1 | 2018 | 23 | 0.160 |
Why?
|
Cohort Studies | 14 | 2024 | 41457 | 0.160 |
Why?
|
Occupational Exposure | 4 | 2018 | 1813 | 0.160 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2020 | 322 | 0.160 |
Why?
|
Genetic Variation | 2 | 2016 | 6561 | 0.160 |
Why?
|
Pancreatic Neoplasms | 1 | 2016 | 5367 | 0.160 |
Why?
|
Pesticides | 1 | 2021 | 296 | 0.150 |
Why?
|
Waist Circumference | 1 | 2022 | 933 | 0.150 |
Why?
|
Immunity, Cellular | 1 | 2004 | 1550 | 0.150 |
Why?
|
Menstrual Cycle | 1 | 2022 | 539 | 0.150 |
Why?
|
United States | 16 | 2024 | 72272 | 0.150 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2018 | 286 | 0.150 |
Why?
|
Efficiency | 1 | 2021 | 476 | 0.150 |
Why?
|
Occupational Diseases | 2 | 2018 | 1490 | 0.150 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2018 | 367 | 0.140 |
Why?
|
Solvents | 1 | 2018 | 294 | 0.140 |
Why?
|
Leukemia, Lymphoid | 1 | 2017 | 310 | 0.140 |
Why?
|
Infertility, Female | 1 | 2023 | 760 | 0.140 |
Why?
|
Linkage Disequilibrium | 2 | 2020 | 1994 | 0.140 |
Why?
|
Resistin | 1 | 2017 | 172 | 0.140 |
Why?
|
Adiponectin | 3 | 2018 | 1107 | 0.140 |
Why?
|
Genetic Loci | 3 | 2016 | 2624 | 0.130 |
Why?
|
Incidence | 10 | 2023 | 21337 | 0.130 |
Why?
|
HLA Antigens | 3 | 2019 | 1329 | 0.130 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2021 | 3244 | 0.130 |
Why?
|
Leukemia | 2 | 2014 | 1520 | 0.120 |
Why?
|
Birth Weight | 1 | 2023 | 2101 | 0.120 |
Why?
|
Adolescent | 20 | 2024 | 88234 | 0.120 |
Why?
|
Multifactorial Inheritance | 2 | 2020 | 1380 | 0.120 |
Why?
|
Mosaicism | 1 | 2018 | 474 | 0.120 |
Why?
|
Colorectal Neoplasms | 3 | 2023 | 6925 | 0.120 |
Why?
|
Infectious Mononucleosis | 2 | 2012 | 133 | 0.120 |
Why?
|
Fruit | 2 | 2021 | 1157 | 0.120 |
Why?
|
Vegetables | 2 | 2021 | 1191 | 0.120 |
Why?
|
Interleukin-10 | 2 | 2017 | 1172 | 0.120 |
Why?
|
Reproductive History | 1 | 2015 | 210 | 0.120 |
Why?
|
Hepatitis C | 1 | 2004 | 1579 | 0.110 |
Why?
|
SEER Program | 1 | 2019 | 1450 | 0.110 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2018 | 1434 | 0.110 |
Why?
|
Blood Donors | 1 | 2015 | 345 | 0.110 |
Why?
|
Leukemia, Myeloid | 1 | 2016 | 693 | 0.110 |
Why?
|
Periodontal Diseases | 1 | 2016 | 451 | 0.110 |
Why?
|
Cell Membrane | 1 | 2022 | 3680 | 0.110 |
Why?
|
Logistic Models | 4 | 2018 | 13245 | 0.110 |
Why?
|
Epidemiologic Studies | 1 | 2016 | 673 | 0.100 |
Why?
|
Esophageal Neoplasms | 1 | 2023 | 1653 | 0.100 |
Why?
|
Nutrition Surveys | 1 | 2020 | 1723 | 0.100 |
Why?
|
Japan | 2 | 2009 | 1372 | 0.100 |
Why?
|
Weight Loss | 1 | 2024 | 2682 | 0.100 |
Why?
|
Meat | 1 | 2015 | 584 | 0.100 |
Why?
|
Antibody Formation | 1 | 2017 | 1390 | 0.100 |
Why?
|
Major Histocompatibility Complex | 1 | 2015 | 870 | 0.100 |
Why?
|
Anticarcinogenic Agents | 1 | 2013 | 249 | 0.100 |
Why?
|
Aged, 80 and over | 16 | 2021 | 58894 | 0.100 |
Why?
|
Chromosome Aberrations | 1 | 2018 | 1768 | 0.100 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2024 | 2291 | 0.100 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2018 | 1348 | 0.100 |
Why?
|
Lipid Metabolism | 1 | 2020 | 1896 | 0.090 |
Why?
|
Carbonated Beverages | 1 | 2012 | 210 | 0.090 |
Why?
|
Austria | 2 | 2022 | 206 | 0.090 |
Why?
|
Sex Factors | 5 | 2024 | 10548 | 0.090 |
Why?
|
Survival Analysis | 2 | 2021 | 10073 | 0.090 |
Why?
|
Dietary Sucrose | 1 | 2012 | 243 | 0.090 |
Why?
|
Leisure Activities | 1 | 2012 | 308 | 0.090 |
Why?
|
Models, Genetic | 1 | 2020 | 3431 | 0.090 |
Why?
|
Air Pollutants | 1 | 2024 | 2893 | 0.090 |
Why?
|
Birth Order | 1 | 2010 | 95 | 0.090 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2011 | 276 | 0.090 |
Why?
|
Sweetening Agents | 1 | 2012 | 290 | 0.090 |
Why?
|
Hormone Replacement Therapy | 1 | 2015 | 750 | 0.090 |
Why?
|
Telomere | 1 | 2016 | 940 | 0.080 |
Why?
|
Energy Intake | 1 | 2017 | 2132 | 0.080 |
Why?
|
Haplotypes | 3 | 2014 | 2713 | 0.080 |
Why?
|
Waldenstrom Macroglobulinemia | 1 | 2018 | 1073 | 0.080 |
Why?
|
Environmental Exposure | 1 | 2024 | 4483 | 0.080 |
Why?
|
Jamaica | 1 | 2009 | 54 | 0.080 |
Why?
|
Genotype | 6 | 2020 | 12978 | 0.080 |
Why?
|
Registries | 3 | 2021 | 8207 | 0.080 |
Why?
|
Vitamin B Complex | 1 | 2011 | 299 | 0.080 |
Why?
|
Methionine | 1 | 2011 | 572 | 0.080 |
Why?
|
Massachusetts | 4 | 2019 | 8833 | 0.080 |
Why?
|
Human T-lymphotropic virus 1 | 1 | 2009 | 142 | 0.080 |
Why?
|
Liver Neoplasms | 1 | 2024 | 4308 | 0.080 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2023 | 2423 | 0.080 |
Why?
|
Antigens, Viral | 2 | 2010 | 987 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2020 | 1846 | 0.080 |
Why?
|
Smoking | 4 | 2023 | 9050 | 0.070 |
Why?
|
Health Personnel | 2 | 2024 | 3333 | 0.070 |
Why?
|
Australia | 3 | 2017 | 1248 | 0.070 |
Why?
|
Sweden | 2 | 2021 | 1379 | 0.070 |
Why?
|
Risk Assessment | 4 | 2020 | 23972 | 0.070 |
Why?
|
Gene Frequency | 3 | 2020 | 3601 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2017 | 3800 | 0.070 |
Why?
|
Inflammation | 3 | 2024 | 10760 | 0.070 |
Why?
|
HIV Infections | 1 | 2013 | 17337 | 0.070 |
Why?
|
Sex Distribution | 2 | 2019 | 2278 | 0.070 |
Why?
|
Women's Health | 1 | 2016 | 2065 | 0.070 |
Why?
|
Postmenopause | 1 | 2015 | 2511 | 0.070 |
Why?
|
Genetic Association Studies | 1 | 2016 | 2734 | 0.070 |
Why?
|
Electronic Health Records | 2 | 2022 | 4803 | 0.070 |
Why?
|
Age Distribution | 2 | 2019 | 2871 | 0.070 |
Why?
|
Immunoglobulin E | 2 | 2017 | 1502 | 0.060 |
Why?
|
Mendelian Randomization Analysis | 2 | 2023 | 1007 | 0.060 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2020 | 12142 | 0.060 |
Why?
|
Homosexuality, Male | 1 | 2013 | 1333 | 0.060 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2020 | 4020 | 0.060 |
Why?
|
Utah | 1 | 2024 | 129 | 0.060 |
Why?
|
Overweight | 1 | 2016 | 2417 | 0.060 |
Why?
|
Pandemics | 2 | 2023 | 8645 | 0.060 |
Why?
|
Receptors, IgE | 1 | 2006 | 375 | 0.060 |
Why?
|
Folic Acid | 1 | 2011 | 1323 | 0.060 |
Why?
|
Prognosis | 5 | 2019 | 29600 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3351 | 0.060 |
Why?
|
Membrane Glycoproteins | 1 | 2015 | 3688 | 0.060 |
Why?
|
Socioeconomic Factors | 2 | 2015 | 7798 | 0.060 |
Why?
|
Tuberculin Test | 1 | 2004 | 206 | 0.060 |
Why?
|
Health Behavior | 1 | 2015 | 2643 | 0.060 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2019 | 3612 | 0.050 |
Why?
|
Mutation | 2 | 2019 | 30016 | 0.050 |
Why?
|
Fatty Acid Desaturases | 1 | 2023 | 100 | 0.050 |
Why?
|
Europe | 3 | 2014 | 3413 | 0.050 |
Why?
|
Databases, Factual | 1 | 2018 | 7960 | 0.050 |
Why?
|
Serologic Tests | 1 | 2004 | 381 | 0.050 |
Why?
|
Alleles | 3 | 2019 | 6861 | 0.050 |
Why?
|
Anti-Asthmatic Agents | 2 | 1996 | 574 | 0.050 |
Why?
|
B-Lymphocytes | 3 | 2022 | 4745 | 0.050 |
Why?
|
Government | 1 | 2022 | 160 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2020 | 5812 | 0.050 |
Why?
|
Intention | 1 | 2024 | 346 | 0.050 |
Why?
|
North America | 2 | 2014 | 1273 | 0.040 |
Why?
|
Alcohol Drinking | 1 | 2013 | 4025 | 0.040 |
Why?
|
Yogurt | 1 | 2020 | 71 | 0.040 |
Why?
|
NF-kappa B | 1 | 2009 | 2481 | 0.040 |
Why?
|
Quality Control | 1 | 2023 | 831 | 0.040 |
Why?
|
Hypersensitivity | 1 | 2009 | 1167 | 0.040 |
Why?
|
Puberty | 1 | 2023 | 501 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2016 | 14591 | 0.040 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2023 | 540 | 0.040 |
Why?
|
Cause of Death | 2 | 2021 | 3683 | 0.040 |
Why?
|
Quality of Life | 1 | 2021 | 13347 | 0.040 |
Why?
|
Quantitative Trait Loci | 2 | 2020 | 2112 | 0.040 |
Why?
|
Algorithms | 1 | 2019 | 14018 | 0.040 |
Why?
|
Chromosome Fragile Sites | 1 | 2018 | 26 | 0.040 |
Why?
|
Mortality | 2 | 2021 | 2899 | 0.040 |
Why?
|
Confidence Intervals | 1 | 2004 | 2925 | 0.040 |
Why?
|
Germ Cells | 1 | 2022 | 634 | 0.040 |
Why?
|
Adrenergic beta-Agonists | 2 | 1997 | 346 | 0.040 |
Why?
|
Comorbidity | 3 | 2021 | 10505 | 0.040 |
Why?
|
Immunoglobulin M | 1 | 2023 | 1526 | 0.040 |
Why?
|
Chromosome Breakage | 1 | 2018 | 159 | 0.040 |
Why?
|
Lymphocyte Activation | 1 | 2009 | 5463 | 0.040 |
Why?
|
Puerto Rico | 1 | 2019 | 378 | 0.040 |
Why?
|
Ghana | 1 | 2019 | 315 | 0.040 |
Why?
|
Meta-Analysis as Topic | 2 | 2015 | 1380 | 0.040 |
Why?
|
Bone Neoplasms | 2 | 2023 | 2527 | 0.040 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2018 | 277 | 0.040 |
Why?
|
Fenoterol | 1 | 1997 | 2 | 0.040 |
Why?
|
Chromosome Mapping | 2 | 2017 | 4611 | 0.040 |
Why?
|
United States Department of Defense | 1 | 2017 | 34 | 0.040 |
Why?
|
Asthma | 4 | 1997 | 6233 | 0.040 |
Why?
|
Receptors, Leptin | 1 | 2018 | 350 | 0.040 |
Why?
|
Reference Values | 1 | 2004 | 4919 | 0.030 |
Why?
|
Lipoproteins, LDL | 1 | 2020 | 642 | 0.030 |
Why?
|
C-Peptide | 1 | 2018 | 440 | 0.030 |
Why?
|
Chemokines | 1 | 2021 | 954 | 0.030 |
Why?
|
Penetrance | 1 | 2018 | 382 | 0.030 |
Why?
|
Transmembrane Activator and CAML Interactor Protein | 1 | 2016 | 55 | 0.030 |
Why?
|
Inheritance Patterns | 1 | 2018 | 341 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2023 | 26049 | 0.030 |
Why?
|
Molecular Sequence Annotation | 1 | 2018 | 520 | 0.030 |
Why?
|
Hypercalcemia | 1 | 2019 | 423 | 0.030 |
Why?
|
Linear Models | 1 | 2006 | 5866 | 0.030 |
Why?
|
Urinary Bladder Neoplasms | 2 | 2020 | 2223 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2019 | 3634 | 0.030 |
Why?
|
Lipoproteins, HDL | 1 | 2020 | 675 | 0.030 |
Why?
|
Survival Rate | 2 | 2020 | 12719 | 0.030 |
Why?
|
Health | 1 | 2018 | 398 | 0.030 |
Why?
|
Carcinoma, Basal Cell | 1 | 2020 | 557 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2022 | 15251 | 0.030 |
Why?
|
Tooth Loss | 1 | 2016 | 200 | 0.030 |
Why?
|
Genes, Reporter | 1 | 2018 | 1525 | 0.030 |
Why?
|
Genetic Heterogeneity | 1 | 2018 | 733 | 0.030 |
Why?
|
Serpins | 1 | 2016 | 247 | 0.030 |
Why?
|
Dioxygenases | 1 | 2016 | 344 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2015 | 550 | 0.030 |
Why?
|
Proto-Oncogene Proteins | 2 | 2016 | 4512 | 0.030 |
Why?
|
Health Maintenance Organizations | 1 | 1996 | 658 | 0.030 |
Why?
|
Rural Population | 1 | 2004 | 2276 | 0.030 |
Why?
|
Causality | 1 | 2020 | 1240 | 0.030 |
Why?
|
Alveolar Bone Loss | 1 | 2016 | 390 | 0.030 |
Why?
|
T-Box Domain Proteins | 1 | 2016 | 469 | 0.030 |
Why?
|
Body Weight | 1 | 2024 | 4614 | 0.030 |
Why?
|
Aspartame | 1 | 2012 | 19 | 0.030 |
Why?
|
Green Fluorescent Proteins | 1 | 2018 | 2063 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2023 | 20074 | 0.030 |
Why?
|
Biological Specimen Banks | 1 | 2018 | 778 | 0.030 |
Why?
|
Computational Biology | 2 | 2015 | 3509 | 0.030 |
Why?
|
Neoplasm Staging | 2 | 2019 | 11116 | 0.030 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2013 | 313 | 0.030 |
Why?
|
American Cancer Society | 1 | 2012 | 69 | 0.020 |
Why?
|
Triglycerides | 1 | 2020 | 2459 | 0.020 |
Why?
|
Bacteria | 1 | 2023 | 2192 | 0.020 |
Why?
|
Time Factors | 1 | 2013 | 39913 | 0.020 |
Why?
|
Age Factors | 3 | 2018 | 18381 | 0.020 |
Why?
|
5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 1 | 2011 | 28 | 0.020 |
Why?
|
Thymidylate Synthase | 1 | 2011 | 74 | 0.020 |
Why?
|
Retrospective Studies | 5 | 2022 | 80566 | 0.020 |
Why?
|
Kidney Neoplasms | 2 | 2020 | 4250 | 0.020 |
Why?
|
Ovarian Cysts | 1 | 1992 | 108 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2009 | 10175 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2014 | 991 | 0.020 |
Why?
|
Heterozygote | 1 | 2018 | 2780 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2021 | 10754 | 0.020 |
Why?
|
Cholesterol | 1 | 2020 | 2903 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2016 | 1134 | 0.020 |
Why?
|
Leptin | 1 | 2018 | 1595 | 0.020 |
Why?
|
Occupations | 1 | 2013 | 516 | 0.020 |
Why?
|
Receptors, Cell Surface | 1 | 2020 | 2802 | 0.020 |
Why?
|
Drug Industry | 1 | 1997 | 788 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2020 | 6807 | 0.020 |
Why?
|
Contraceptives, Oral | 1 | 1992 | 553 | 0.020 |
Why?
|
Anemia | 1 | 2019 | 1504 | 0.020 |
Why?
|
History, 21st Century | 1 | 2015 | 1565 | 0.020 |
Why?
|
Testicular Neoplasms | 1 | 2015 | 800 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2018 | 4269 | 0.020 |
Why?
|
Prevalence | 2 | 2024 | 15689 | 0.020 |
Why?
|
Animals | 2 | 2020 | 168201 | 0.020 |
Why?
|
Acute Disease | 2 | 2016 | 7237 | 0.020 |
Why?
|
Vaccination | 1 | 2021 | 3370 | 0.020 |
Why?
|
Recombination, Genetic | 1 | 2013 | 1519 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2020 | 5780 | 0.020 |
Why?
|
Carbon | 1 | 2011 | 665 | 0.020 |
Why?
|
Public Health | 1 | 2021 | 2669 | 0.020 |
Why?
|
Military Personnel | 1 | 2017 | 1245 | 0.020 |
Why?
|
Family | 1 | 2018 | 3193 | 0.020 |
Why?
|
History, 20th Century | 1 | 2015 | 2764 | 0.020 |
Why?
|
Base Sequence | 1 | 2018 | 12421 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2014 | 2700 | 0.020 |
Why?
|
Capsid Proteins | 1 | 2010 | 464 | 0.020 |
Why?
|
DNA Primers | 1 | 2011 | 2817 | 0.020 |
Why?
|
Anemia, Hemolytic | 1 | 2008 | 162 | 0.020 |
Why?
|
Fractures, Bone | 1 | 2019 | 2044 | 0.020 |
Why?
|
Food | 1 | 2011 | 768 | 0.020 |
Why?
|
Siblings | 1 | 2010 | 824 | 0.020 |
Why?
|
Sjogren's Syndrome | 1 | 2008 | 237 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2016 | 2985 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2016 | 2895 | 0.020 |
Why?
|
Population Surveillance | 1 | 2015 | 2595 | 0.020 |
Why?
|
Blood Glucose | 1 | 2018 | 6390 | 0.010 |
Why?
|
Insulin | 1 | 2018 | 6593 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2017 | 12043 | 0.010 |
Why?
|
Lung Neoplasms | 2 | 2020 | 13382 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2015 | 4341 | 0.010 |
Why?
|
Demography | 1 | 2008 | 1643 | 0.010 |
Why?
|
Vitamins | 1 | 2011 | 1635 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2018 | 10432 | 0.010 |
Why?
|
Disease Progression | 1 | 2019 | 13495 | 0.010 |
Why?
|
MicroRNAs | 1 | 2018 | 3805 | 0.010 |
Why?
|
Boston | 2 | 2011 | 9313 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2012 | 2637 | 0.010 |
Why?
|
Self Report | 1 | 2012 | 3723 | 0.010 |
Why?
|
Celiac Disease | 1 | 2008 | 819 | 0.010 |
Why?
|
Psoriasis | 1 | 2008 | 944 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2016 | 9586 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2020 | 9026 | 0.010 |
Why?
|
Child | 3 | 2023 | 80079 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2016 | 7847 | 0.010 |
Why?
|
Cell Lineage | 1 | 2008 | 2554 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2016 | 5835 | 0.010 |
Why?
|
New Zealand | 1 | 1997 | 358 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2023 | 64568 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2021 | 15498 | 0.010 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2008 | 2152 | 0.010 |
Why?
|
Theophylline | 1 | 1995 | 131 | 0.010 |
Why?
|
Administration, Inhalation | 1 | 1997 | 1156 | 0.010 |
Why?
|
Pharmacoepidemiology | 1 | 1997 | 350 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2020 | 20988 | 0.010 |
Why?
|
Arthritis, Rheumatoid | 1 | 2008 | 3752 | 0.010 |
Why?
|
Community Health Services | 1 | 1995 | 654 | 0.010 |
Why?
|
Patient Admission | 1 | 1996 | 1365 | 0.010 |
Why?
|
Drug Utilization | 1 | 1995 | 1186 | 0.000 |
Why?
|
Disease Outbreaks | 1 | 1997 | 1748 | 0.000 |
Why?
|
Medical Records | 1 | 1992 | 1407 | 0.000 |
Why?
|
Adrenal Cortex Hormones | 1 | 1995 | 1879 | 0.000 |
Why?
|
Hospitalization | 2 | 1996 | 10704 | 0.000 |
Why?
|
Child, Preschool | 2 | 1997 | 42188 | 0.000 |
Why?
|
Emergency Medical Services | 1 | 1995 | 1921 | 0.000 |
Why?
|
Intensive Care Units | 1 | 1996 | 3742 | 0.000 |
Why?
|
Drug Prescriptions | 1 | 1992 | 1669 | 0.000 |
Why?
|
Health Care Costs | 1 | 1995 | 3238 | 0.000 |
Why?
|
Infant | 1 | 1996 | 36152 | 0.000 |
Why?
|
Pregnancy | 1 | 1992 | 29868 | 0.000 |
Why?
|